Copyright
©The Author(s) 2025.
World J Gastrointest Pathophysiol. Sep 22, 2025; 16(3): 108952
Published online Sep 22, 2025. doi: 10.4291/wjgp.v16.i3.108952
Published online Sep 22, 2025. doi: 10.4291/wjgp.v16.i3.108952
Table 1 Key microbial metabolites and their effects on the gut-skin axis
| Metabolite | Produced by | Effects on gut | Effects on skin |
| SCFAs (e.g., butyrate) | Firmicutes (e.g., Faecalibacterium) | Enhances gut barrier, anti-inflammatory | Promotes tregs, reduces inflammation |
| p-Cresol | Clostridium difficile | Increases gut permeability | Decreases keratinocyte differentiation, causes xerosis |
| Indole derivatives | Tryptophan metabolism | Modulates intestinal immunity via AhR | Influences skin inflammation and barrier repair |
| Zonulin | Enteric epithelial cells | Increases intestinal permeability ("leaky gut") | May indirectly increase risk of inflammation-related dermatoses |
| Serotonin | Enterochromaffin cells/gut flora | Gut motility, mood regulation | Implicated in pruritus and neurogenic inflammation |
| Trimethylamine-N-oxide | Gut bacteria metabolizing choline/carnitine (e.g., Lachnoclostridium) | Increases systemic inflammation and oxidative stress; implicated in metabolic dysfunction | May contribute to skin aging and inflammatory dermatoses (indirectly via systemic effects) |
Table 2 Shared cytokine pathways in gut and skin disorders
| Cytokine | Source | Role in gut disease | Role in skin disease |
| IL-17 | Th17 cells | Promotes mucosal inflammation in Crohn’s disease; may have protective roles in UC | Drives psoriasis, AD |
| IL-23 | Dendritic cells, macrophages | Supports Th17 expansion in IBD | Involved in psoriatic inflammation |
| TNF-α | Macrophages, monocytes | Central to both Crohn’s and UC pathogenesis | Targeted in psoriasis, hidradenitis suppurativa |
| IL-4 | Th2 cells | Mucosal immunity shift in some IBD variants | Hallmark of atopic dermatitis |
| IL-6 | Multiple immune cells | Acute phase reactant in IBD | Links gut-brain-skin inflammation |
| IFN-γ | Th1 cells | Epithelial barrier disruption | Found in psoriatic and alopecia lesions |
| IL-22 | Th17 cells, innate lymphoid cells | Promotes epithelial regeneration, but may drive pathology in IBD (e.g., UC) | Promotes keratinocyte proliferation in psoriasis |
Table 3 Common diseases/syndromes with their gastrointestinal and skin manifestations
| Disease/syndrome | Skin manifestations | Associated GI malignancy | GI and other features |
| Muir Torre syndrome (Variant of Lynch syndrome) | Sebaceous adenoma. Epitheliomas. Multiple keratocanthomas | Colon, gastric, hepatobiliary, pancreas | Cancer involving endometrium, cervix, lung, urological, blood, ovary |
| Gardner syndrome | Epidermoid cysts. Lipomas. Desmoid tumors | Colorectal, duodenal, hepatoblastoma, stomach | CHRPE, supernumerary teeth, adrenal tumors, osteomas |
| Peutz Jegher’s syndrome | Hyperpigmentation of tongue. Pigmentation around lips around mouth | Duodenal, colon, pancreas, stomach, small bowel | Cancer involving pancreas, breast, ovary, genitals |
| Cowden syndrome | Trichilemmomas. Oral papillomatosis. Facial papules. Acral keratoses | Colon | Melanoma, cancer involving endometrium, thyroid, kidney |
| Bannayan-Riley-Ruvalcaba syndrome | Hyperpigmented macules involving Glans penis or vulva. Acanthosis nigricans. Facial verrucous papules | None | Macrocephaly, hypotonia, autism spectrum disorder, development delay, hamartomas, seizures, scoliosis |
| Juvenile polyposis syndrome | Digital clubbing. Facial and digital telangiectasias | Colon, SI, stomach | Cancer involving. Pancreas |
| Cronkhite Canada syndrome | Nail dystrophy. Alopecia. Hyperpigmentation | Gastric, colon | Intestinal mucosal changes leading to malabsorption |
| Bazex syndrome (Acrokeratosis Paraneoplastica) | Scaly. Psoriasiform plaques on acral areas, and nasal, ear and malar surfaces | Upper GI tract | SCC of pharynx, esophagus, larynx, lung, lymphoma and genito-urinary tumors |
| Tylosis | Palmoplantar hyperkeratosis | Esophagus (SCC) | |
| Plummer Vinson syndrome | Koilonychia | Esophagus (SCC) | Esophageal web, iron deficiency |
| Glucagonoma and Necrolytic Migratory erythema | Annular erythematous eruption with blisters. Ngular cheilitis. Glossitis. Stomatitis | Anemia, weight loss, diarrhoea, steatorrhoea, thromboembolic disease, psychiatry disturbance | |
| Carcinoid syndrome | Flushing. Rosacea. Pellagra like changes. Cutaneous metastasis | Appendix, small intestine | Wheezing, carcinoid heart disease, diarrhoea |
| Paraneoplastic dermatomyositis | Heliotropic rash. Gottron papules. Violaceous poikiloderma. Ragged cuticle. Nail fold telangiectasias | Stoamch, colorectal, pancreas | Dermatomyositis, cancer involving lung and ovary, lymphomas |
| Cutaneous metastasis | Sister Joseph Mary nodule on umbilicus | Gastric adenocarcinoma |
Table 4 Gut-skin axis–linked diseases and their microbial dysbiosis profiles
| Condition | Gut microbiome changes | Skin microbiome changes |
| Atopic dermatitis | ↓Bifidobacteria, ↓F. prausnitzii, ↑Enterobacteriaceae | ↑S. aureus, ↓microbial diversity |
| Psoriasis | ↑Ruminococcus, ↓Akkermansia muciniphila, ↓Faecalibacterium prausnitzii | ↑Corynebacterium, ↑Streptococcus |
| Rosacea | ↑Prevotella intermedia, ↓Cutibacterium | ↑Demodex folliculorum, ↑Gordonia |
| Hidradenitis suppurativa | ↑Porphyromonas, ↑Prevotella, ↓diversity | ↑anaerobes in lesions, ↓alpha diversity |
| Celiac disease | ↑Proteobacteria, ↓Lactobacillus, ↑Candida | Associated with dermatitis herpetiformis |
| Seborrheic dermatitis | Altered lipid metabolism-related bacteria (e.g., ↑Enterobacteriaceae) | ↑Malassezia species (esp. M. restricta), altered yeast load |
| Acne vulgaris | ↓Lactobacillus, ↑Proteobacteria, ↓diversity | ↑Cutibacterium acnes (formerly Propionibacterium acnes) |
- Citation: Singla N, Singla K, Attauabi M, Aggarwal D. Gut-skin axis: Emerging insights for gastroenterologists-a narrative review. World J Gastrointest Pathophysiol 2025; 16(3): 108952
- URL: https://www.wjgnet.com/2150-5330/full/v16/i3/108952.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v16.i3.108952
